Biotech China 2014
7th Annual QT Prolongation and Safety Pharmacology
Swissôtel Le Plaza
BaselMesseplatz 25,
Basel,, Switzerland
QT Prolongation and Safety Pharmacology
Informa Life Sciences
Swissôtel Le Plaza 

Schedule of Presentations:

Wednesday, June 3, 2009
08:00:00 Conference registration and morning coffee
08:30:00 Opening remarks from the Chairperson
08:35:00 Conclusions from a review of ICH S7 guidelines Gerd Bode
09:05:00 Overview of recent Q&A with E14 working group and the impacts for your future trial designs Charles T Benson
09:35:00 Regulations Q&A
09:45:00 Effectively predicting QT prolongation in humans
10:20:00 Morning coffee
11:00:00 The translatability of existing and emerging preclinical cardiotoxicity assays Matthew J Killeen
11:35:00 Stem cells as a tool in preclinical testing for QT prolongation Martin Traebert
12:10:00 Spotlight session
12:45:00 Lunch
14:15:00 Bridging the gap between non-clinical and clinical studies Wilhelm Haverkamp
14:50:00 Drug induced QT/QTc prolongation - Review of one-stage vs. two-stage methods to analyse clinical ECG data Jianguo Li
15:25:00 Afternoon tea and high speed networking
16:05:00 Designing a tQT study for limited resources Arne Ring
16:40:00 Methods for reducing variability in QT assessment Henry Holzgrefe
17:15:00 Applications of mixed models in tQT studies Dennis Chanter
17:50:00 Closing remarks from the Chairperson
17:55:00 End of day one
Thursday, June 4, 2009
08:30:00 Opening remarks from the Chairperson
08:35:00 Assessing the risk of proarrythmia? Danshi Li
09:10:00 Three years post E14 guidance – Challenges and potential solutions Sasha Latypova
09:45:00 Cardiac safety strategies for FIM studies for biopharmaceuticals Alexander Breidenbach
10:20:00 Morning coffee and "meet the author" poster session
11:00:00 QT study design for oncology drugs Corina-Dana Dota,
11:30:00 Unwanted QT problems in oncology programmes - A hERG trafficking case study Bérengère Dumotier
12:00:00 Q&A session - What have we learned from oncology QT studies to date?
12:10:00 Spotlight session
12:45:00 Lunch
14:10:00 Drug related change in the ECG - A novel biomarker for cardiac risk? Christer Gottfridsson
14:45:00 Optimized Holter extractions in tQT studies Fabio Badilini
15:20:00 Afternoon tea
15:50:00 Increasing power through developing technologies - 12 lead ECG to continuous recording methods Corina-Dana Dota,
16:25:00 Assessing the risk of Na channel inhibition Danshi Li
17:00:00 Closing remarks from the Chairperson
17:10:00 End of conference
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.